Trials / Sponsors / Greg Durm, MD
Greg Durm, MD
Academic / Other · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSC NSCLC, Stage I | Phase 2 | 2020-05-05 |
| Terminated | Chemoradiation Plus Durvalumab Followed by Surgery Followed by Adjuvant Durvalumab in Patients With Surgically Non Small Cell Lung Cancer, Stage III Non-small-cell Lung Cancer | Phase 2 | 2019-08-02 |
| Completed | Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC) Non-small Cell Lung Cancer | Phase 2 | 2017-09-15 |
| Completed | Phase II Trial of Continuation Therapy in Advanced NSCLC Non-Small-Cell Lung Cancer | Phase 2 | 2017-03-20 |